← Open Payments lookup

DANIEL MAI: Open Payments

NPI 1811770134 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,068 in 231 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $6,919 · 2025 $6,068

Food & beverage: $6,068
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc23$837
Vanda Pharmaceuticals Inc.25$719
E.R. Squibb & Sons, L.L.C.22$701
Neurocrine BioSciences, Inc.18$687
ABBVIE INC.26$570
Otsuka America Pharmaceutical, Inc.17$552
Teva Pharmaceuticals USA, Inc.17$417
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$394
Biogen, Inc.10$243
Alkermes, Inc.9$193

Products named: FANAPT, INGREZZA, COBENFY, SPRAVATO, VRAYLAR, REXULTI, CAPLYTA, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.